Central Data Catalog

Citations

1 Bjerregaard-Andersen, Morten, Margarida A Gomes, Luis C Joaquím, Amabelia Rodrigues, Dorte M Jensen, Kaare Christensen, Christine S Benn, Peter Aaby, Henning Beck-Nielsen, and Morten Sodemann. "Establishing a twin registry in Guinea-Bissau." Twin Res Hum Genet 16, no. 1 (2013): 179-184.
2 Bjerregaard-Andersen, Morten, Najaaraq Lund, Frida Staarup Jepsen, Luis Camala, Margarida Alfredo Gomes, Kaare Christensen, Lene Christiansen, Dorte Møller Jensen, Peter Aaby, Henning Beck-Nielsen, Christine Stabell Benn, and Morten Sodemann. "A prospective study of twinning and perinatal mortality in urban Guinea-Bissau." BMC Pregnancy Childbirth (2012).
3 Crameri, Andreas, Jutta Marfurt, Kefas Mugittu, Nicolas Maire, Attila Regös, Jean Yves Coppee, Odile Sismeiro, Richard Burki, Eric Huber, Daniel Laubscher, Odile Puijalon, Blaise Genton, Ingrid Felger, and Hans-Peter Beck. "Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs." J. Clin. Microbiol. (2007).
4 Dynes, Michelle, Aminur Rahman, Diana Beck, Allisyn Moran, Anisur Rahman, Jesmin Pervin, Mohammad Yunus, Md Harunor Rashid, Tamanna Gazi, Kamal Kanti Biswas, Sandra Buffington, Joan M. Patterson, and Lynn Sibley. "Home-based life saving skills in Matlab, Bangladesh: a process evaluation of a community-based maternal child health programme." Midwifery (2011).
5 Genton, B., F. al Yaman, I. Betuela, R. F. Anders, A. Saul, K. Baea, M. Mellombo, J. Taraika, G. V. Brown, D. Pye, D. O. Irving, I. Felger, H. P. Beck, T. Smith, and M. Alpers. "Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children." (2003).
6 Genton, Blaise, Inoni Betuela, Ingrid Felger, Fadwa Al-Yaman, Robin F Anders, Allan Saul, Lawrence Rare, Moses Baisor, Kerry Lorry, Graham V Brown, David Pye, David O Irving, Thomas A Smith, Hans-Peter Beck, and Michael P Alpers. "A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea." J. Infect. Dis. 185, no. 6 (2002): 820-827.
7 Henning, L., D. Schellenberg, T. Smith, D. Henning, P. Alonso, M. Tanner, H. Mshinda, H. P. Beck, and I. Felger. "A prospective study of Plasmodium falciparum multiplicity of infection and morbidity in Tanzanian children." Trans. R. Soc. Trop. Med. Hyg. (2004).
8 Hodel, Eva Maria, Abdunoor Mulokozi Kabanywanyi, Aggrey Malila, Boris Zanolari, Thomas Mercier, Hans-Peter Beck, Thierry Buclin, Piero Olliaro, Laurent Arthur Decosterd, and Blaise Genton. "Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance." PLoS ONE (2009).
9 Makanga, Michael, Quique Bassat, Catherine O Falade, Zulfiqarali G Premji, Srivicha Krudsood, Philip Hunt, Verena Walter, Hans-Peter Beck, Anne-Claire Marrast, Marc Cousin, and Philip J Rosenthal. "Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis." Am. J. Trop. Med. Hyg. 85, no. 5 (2011): 793-804.
10 Marfurt, Jutta, Ivo Müller, Albert Sie, Olive Oa, John C Reeder, Thomas A Smith, Hans-Peter Beck, and Blaise Genton. "The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea." Malar. J. (2008).
11 Mugittu, Kefas, Salim Abdulla, Nicole Falk, Honorati Masanja, Ingrid Felger, Hassan Mshinda, Hans-Peter Beck, and Blaise Genton. "Efficacy of sulfadoxine-pyrimethamine in Tanzania after two years as first-line drug for uncomplicated malaria: assessment protocol and implication for treatment policy strategies." Malar. J. (2005).
12 Mugittu, Kefas, Martin Adjuik, Georges Snounou, Francine Ntoumi, Walter Taylor, Hassan Mshinda, Piero Olliaro, and Hans-Peter Beck. "Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness." Trop. Med. Int. Health (2006).
13 Mugittu, Kefas, Blaise Genton, Hassan Mshinda, and Hans Peter Beck. "Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania." Malar. J. (2006).
14 Mugittu, Kefas, Modesta Ndejembi, Allen Malisa, Martha Lemnge, Zulfikar Premji, Alex Mwita, Watoky Nkya, Johannes Kataraihya, Salim Abdulla, Hans-Peter Beck, and Hassan Mshinda. "Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo re." Am. J. Trop. Med. Hyg. (2004).
15 Mugittu, Kefas, Gerardo Priotto, Jean-Paul Guthmann, James Kiguli, Martin Adjuik, Georges Snounou, Hans-Peter Beck, Hassan Mshinda, Piero L. Olliaro, and Walter R. J. Taylor. "Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment." Trop. Med. Int. Health (2007).
16 Mwingira, Felista, Gamba Nkwengulila, Sonja Schoepflin, Deborah Sumari, Hans-Peter Beck, Georges Snounou, Ingrid Felger, Piero Olliaro, and Kefas Mugittu. "Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa." Malar. J. (2011).